Clinical Trials Logo

Pulmonary Edema clinical trials

View clinical trials related to Pulmonary Edema.

Filter by:

NCT ID: NCT04483843 Completed - Clinical trials for Pulmonary Edema Cardiac Cause

Cosmic Weather and Cardiogenic Pulmonary Edema

Start date: March 1, 2019
Phase:
Study type: Observational

Retrospective clinical study to evaluate whether there is any correlation between the pre-hospital incidence of cardiogenic pulmonary oedema (CPE) in the selected region and the space weather parameters.

NCT ID: NCT04186598 Completed - Clinical trials for Continuous Positive Airway Pressure

Evaluating the Utility of Continuous Positive Airway Pressure in the Treatment of High Altitude Pulmonary Edema

Start date: January 20, 2020
Phase: N/A
Study type: Interventional

The primary objective is to evaluate the efficacy of continuous positive pressure on resolution of high-altitude pulmonary edema vs high flow oxygen. The secondary objective is to derive an incidence of high-altitude pulmonary edema based on the elevation and timing from which the subject arrives. Additionally, in a convenience sample of the base study population, an ultrasound evaluation for the presence of B lines in the lungs will be conducted after 2 hours.

NCT ID: NCT04176627 Completed - Clinical trials for Peritoneal Dialysis Complication

Assessing Fluid Status of Peritoneal Dialysis Patients With Assistance of Lung Ultrasound

Fluid-PLUS
Start date: December 2, 2019
Phase:
Study type: Observational

- As studied previously, lung congestion is very prevalent however usually asymptomatic in dialysis patients. Fluid overload is associated with hospitalizations, worse cardiovascular outcomes and mortality in PD patients. - The clinical exam is the only tool used currently to monitor volume status of PD patients, and has been found to have poor sensitivity and specificity for lung congestion compared to lung ultrasound. In current practice, patients are seen and examined monthly at their home dialysis units by the nurses. The nephrologist separately examines the patient monthly, possibly days to weeks after the nurse visit, and potentially only quarterly with the use of telehealth visits. - Lung ultrasound is a relatively simple and cheap tool to assess for lung congestion, with little inter-operator variability and good reproducibility. - There are limited studies of lung ultrasound in peritoneal dialysis, and none in the United States. Lung ultrasound may be useful as an objective measure of lung congestion in patients without signs or symptoms of fluid overload. Aims of this study - This study aims to determine the prevalence of subclinical fluid overload in peritoneal dialysis patients. - The investigators aim to determine the added benefit of lung ultrasound to standard clinical practice of fluid management in PD patients. - The investigators aim to assess the association of patient characteristics with lung congestion. - The investigators also aim to assess the agreement between nurse physical exam and lung ultrasound for fluid overload.

NCT ID: NCT04014088 Completed - Clinical trials for Acute Cardiogenic Pulmonary Edema

Helmet CPAP vs Facemask CPAP in ACPE (hCPAP vs fCPAP)

Start date: January 1, 2016
Phase: N/A
Study type: Interventional

This study objectively held to compare the physiological outcomes in the non-invasive (NIV) treatment of Acute Cardiogenic Pulmonary Edema (ACPE) patients in the Emergency Department (ED) delivered by helmet CPAP (hCPAP) and facemask CPAP (fCPAP).Patients will be randomized to receive either hCPAP or fCPAP.

NCT ID: NCT04005092 Completed - Clinical trials for Cardiogenic Pulmonary Edema

Helmet CPAP Versus HFNC in Acute Cardiogenic Pulmonary Edema

HCPAPvsHFNC
Start date: January 1, 2018
Phase: N/A
Study type: Interventional

This study objectively held to compare the physiological outcomes in the non-invasive (NIV) treatment of Acute Cardiogenic Pulmonary Oedema (ACPE) patients in the Emergency Department (ED) delivered by Helmet CPAP (hCPAP) and HFNC.Patients will be randomized to receive either hCPAP or HFNC.

NCT ID: NCT03883555 Completed - Clinical trials for Hypercapnic Respiratory Failure

High Flow Nasal Cannula Therapy for Early Management of Acute Hypercapnic Cardiogenic Pulmonary Edema in the Emergency Department

preopticap
Start date: February 1, 2015
Phase:
Study type: Observational

High flow nasal therapy (HFNT) has not been well evaluated for treating hypercapnia The purpose of this study is to determine whether high flow nasal therapy (HFNT) can decrease hypercapnia and improve respiratory distress parameters in Emergency Department patients with acute hypercapnic respiratory failure related to cardiogenic pulmonary edema and to compare its efficacy to that of non invasive ventilation.

NCT ID: NCT03768752 Completed - Sepsis Clinical Trials

Diastolic Dysfunction and Interstitial Lung Edema in Septic Patients

Start date: October 11, 2018
Phase:
Study type: Observational

Sepsis is one of the most challenging conditions with an exceptionally high mortality rate. Diastolic Dysfunction is common in septic patients and has been found to be associated with mortality. However, the reasons for this remain unclear. Therefore, the goal of this study is to investigate diastolic dysfunction in septic patients on the intensive care unit. Special attention is paid to the presence of lung edema and general edema as a potential link between diastolic dysfunction and elevated mortality in septic patients. During the septic phase daily ultrasound examinations of heart and lung will be performed as to monitor diastolic function and lung edema.

NCT ID: NCT03740711 Completed - Cardiogenic Shock Clinical Trials

Early LA Venting During Venoaterial ECMO Support

Start date: December 12, 2018
Phase: N/A
Study type: Interventional

The EVOLVE-ECMO(Early Left Atrial Venting Versus Conventional Treatment For Left VEntricular Decompression During Venoarterial ExtraCorporeal Membrane Oxygenation Support) study is a randomized controlled trial to evaluate the prognostic effect of early LA venting(when detect B-line on serial lung ultrasound) on weaning VA-ECMO support in refractory CS who receive VA-ECMO support. The aim of EVOLVE-ECMO trial is to test the hypothesis that early LA venting would result in a significant reduction in failure of weaning ECMO support in refractory CS.

NCT ID: NCT03686813 Completed - Immersion Clinical Trials

Sildenafil for Swimming-Induced Pulmonary Edema (SIPE) Prevention

Start date: July 15, 2019
Phase: Phase 2
Study type: Interventional

This trial is testing the effectiveness of a single oral dose of sildenafil (50 mg) taken 1 hour before a provocative event on the subsequent development of swimming-induced pulmonary edema.

NCT ID: NCT03607201 Completed - Heart Failure Clinical Trials

Acute Coronary Syndrome in Diabetic Patients

Start date: August 1, 2017
Phase:
Study type: Observational

This study aims to compare the clinical profile and outcomes of acute coronary syndrome patients with diabetes and without diabetes.